Stagnant liquid inside an air purification unit, hundreds of complaints on tablet counts and inadequate guidance to call centers are but a few of the litany of issues outlined in the FDA’s Form 483 ...
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1,870 in its research report dated April 23, 2024. Dadra's specialization lies in the ...
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Law Offices of Howard G. Smith announces an investigation on behalf of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) (NASDAQ: SUPN) inv ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
Seamless reading experience. Save your favourite. Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for ...
WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government ...
With the approval of X4 Pharmaceuticals’ first product mavorixafor, there’s a new commercial rare disease player in town. Following a 10-year development journey, the FDA on Monday approved ...
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric ...